newsfilter
← Latest News
PR Newswire·

BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market

  • Bon Natural Life Limited (Nasdaq: BON) announced the successful development of a premium anti-aging facial mask combining apple polyphenols with AI-enabled flexible bio-electronic technology.
  • The mask utilizes advanced transdermal delivery systems to integrate plant-derived active ingredients with smart controlled-release technology for non-invasive, at-home use.
  • Apple polyphenols, extracted from premium apple pomace, contain proanthocyanidins and quercetin known for antioxidant, anti-inflammatory, photoprotective, collagen-protecting, melanin metabolism, and skin firmness-boosting properties.
  • The Company has completed sample development and preliminary internal evaluations showing results exceeding benchmarks for fine lines, skin firmness, UV stress, and overall brightness.
  • BON plans to initiate expanded third-party clinical testing while advancing product finalization and optimizing large-scale manufacturing processes.
  • The product targets the global anti-aging market, which has surpassed $100 billion, aiming to capture a first-mover advantage in the premium transdermal delivery segment.
  • Chairman CEO Hu Yongwei stated the product represents BON's entry into the high-growth medical-grade beauty segment, reinforcing the "AI + Bioactive Ingredient" ecosystem strategy.
  • The initiative aims to establish a second growth engine characterized by strong pricing power, high repurchase potential, attractive margins, and long-term shareholder value.